Abalone Bio (Seed+)

Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Funding URL
View Funding Page
Valuation
$40,000,000

Company Info
Founders
Richard Yu
Company Description
A hybrid biological-computational platform to discover antibody drugs for the world's most difficult diseases. Abalone Bio develops full-spectrum antibody drugs to access promising therapeutic targets and unlock new disease treatments.
Market
Healthcare & Wellness
Coinvestors
BoxOne Ventures,OMX Ventures,Y Combinator

Links
Back to Home Back to Healthcare and Biotech Deals View Funding Announcement